1. Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthritis
- Author
-
Fatemeh Safari, Shafieh Movassaghi, Majid Kabuli, Mojtaba Saffari, Abdolrahman Rostamian, Zeinab Imani-Saber, Mohsen Ghadami, and Elia Damavandi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Inflammation ,Disease ,Real-Time Polymerase Chain Reaction ,Gastroenterology ,Arthritis, Rheumatoid ,Predictive Value of Tests ,Internal medicine ,microRNA ,Murine leukemia virus ,Humans ,Immunology and Allergy ,Diagnostic biomarker ,Medicine ,Circulating MicroRNA ,Rheumatoid arthritis ,Autoimmune disease ,biology ,Reverse Transcriptase Polymerase Chain Reaction ,business.industry ,RNA ,Middle Aged ,Prognosis ,medicine.disease ,biology.organism_classification ,MiR-24-3p ,Up-Regulation ,MicroRNAs ,Case-Control Studies ,MiR-146a ,Female ,medicine.symptom ,business ,Biomarkers - Abstract
Rheumatoid arthritis (RA) is an autoimmune disease that is characterized by inflammation of the articular tissue. This study aims to evaluate the expression of microRNA (miR)-146a-5p, miR-24-3p, and miR-125a-5p in the plasma of RA patients and compare them with those of healthy controls to obtain a specific expression profile for earlier diagnosis and assistance in treating patients. This study was performed on 50 RA patients and 50 healthy controls. Five microliters of blood were taken from each patient/control. Plasma RNA was extracted using the Trisol solution. cDNAs were synthesized; using moloney murine leukemia virus (MMLV) and deoxynucleoside triphosphate (dNTP). Real-time PCR was performed using SYBR green kit. The mean expression of miR-146a-5p, miR-24-3p, and miR-125a-5p in the RA group were 8.1±1.9, 6.5±1.2, and 6.8±2.2 and in the healthy group were 4.8±1.6, 3.6±2.2, and 3.4±1.7, respectively. Significant differences were also observed in the mean expression of these three miRNAs in four subgroups of RA patients with different disease activity based on disease activity score 28 (DAS28) (p
- Published
- 2021